Skip to content

A 9360 · New York · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
New York
/
2025-2026
/
A 9360

New York · 2025-2026 session · house

A 9360Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes

Status: In committee
Latest action: 2026-01-07 — REFERRED TO HEALTH
Primary sponsor: Angelo Santabarbara (Democratic)

Track this bill

Sponsors

Angelo Santabarbara (Democratic) · primaryprimary

Versions

A9360—

Legislative history

Jan 7, 2026

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New York bill RSS

REFERRED TO HEALTH

Dec 19, 2025

REFERRED TO HEALTH

Official sources

Version 0PDF HTML

About this page

Is this the official New York bill page?: No — this is Billy’s public legislative record for A 9360. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track A 9360, get alerts, annotate diffs, and export Word work product.